Ifp Advisors, Inc Tricida, Inc. Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$3.56 - $4.64 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$3.95 - $5.41 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$4.52 - $7.8 $0 - $0	0 New
Q4 2020 Jan 25, 2021	BUY	$4.37 - $9.46 $0 - $0	0 New
Q3 2020 Oct 29, 2020	BUY	$8.56 - $26.93 $0 - $0	0 New

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.